Gain Therapeutics (GANX) Net Long-Term Debt Issued (Repaid) (2020 - 2026)
Gain Therapeutics (GANX) reported Non-Current Debt of $220,058 for Q2 2026, down 32.4% from $325,359 a year earlier and down 19.5% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Net Long-Term Debt Issued (Repaid) (2020 - 2026) Analysis & Trends
At the end of FY2025, Gain Therapeutics posted Non-Current Debt of $300,084, down 8.6% from FY2024.
- Non-Current Debt has declined for five consecutive years, with a five-year compound annual growth rate of -16.0% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $328,327 in FY2024 (-26.9%), $449,053 in FY2023 (-9.3%), $495,258 in FY2022 (-16.1%) and $590,468 in FY2021 (-17.5%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Debt in data going back to Q4 2020.
- Year over year, Non-Current Debt has now declined in each of the last 19 quarters, with an average decline of 18.6% over the last eight quarters.
- The year-over-year decline in Non-Current Debt has ranged between 8.6% (Q4 2025) and 32.4% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $273,265 (Q1 2026), $300,084 (Q4 2025) and $298,797 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.91 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Gain Therapeutics | 47.87 Mn | -14.31 Mn | - | 1.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.78 Mn |
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 427,783.00 |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2020 | 30,396.00 |
| Sep 30, 2020 | 423,288.00 |
| Mar 31, 2020 | 284,598.00 |
API Access
Gain Therapeutics Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();